BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23369554)

  • 21. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions.
    Zeller T; Rastan A; Macharzina R; Tepe G; Kaspar M; Chavarria J; Beschorner U; Schwarzwälder U; Schwarz T; Noory E
    J Endovasc Ther; 2014 Jun; 21(3):359-68. PubMed ID: 24915582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percutaneous transluminal angioplasty and stent placement for recurrent carotid artery stenosis.
    Lanzino G; Mericle RA; Lopes DK; Wakhloo AK; Guterman LR; Hopkins LN
    J Neurosurg; 1999 Apr; 90(4):688-94. PubMed ID: 10193614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome of aortoiliac, femoropopliteal and infrapopliteal endovascular interventions in lesions categorised by TASC classification.
    Ratnam L; Raza SA; Horton A; Taylor J; Markose G; Munneke G; Morgan R; Belli AM
    Clin Radiol; 2012 Oct; 67(10):949-54. PubMed ID: 22947210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
    McQuade K; Gable D; Pearl G; Theune B; Black S
    J Vasc Surg; 2010 Sep; 52(3):584-90; discussion 590-1, 591.e1-591.e7. PubMed ID: 20598480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease).
    Lammer J; Zeller T; Hausegger KA; Schaefer PJ; Gschwendtner M; Mueller-Huelsbeck S; Rand T; Funovics M; Wolf F; Rastan A; Gschwandtner M; Puchner S; Ristl R; Schoder M
    J Am Coll Cardiol; 2013 Oct; 62(15):1320-7. PubMed ID: 23831445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Percutaneous revascularization of femoropopliteal artery disease: PTA and PTA plus stent. Results after six years' follow-up.
    Pozzi Mucelli F; Fisicaro M; Calderan L; Malacrea M; Mazzone C; Cattin L; Scardi S; Pozzi Mucelli R
    Radiol Med; 2003 Apr; 105(4):339-49. PubMed ID: 12835627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of "cutting" balloon angioplasty for the treatment of short femoral bifurcation steno-obstructive disease.
    Cotroneo AR; Iezzi R
    Cardiovasc Intervent Radiol; 2010 Oct; 33(5):921-8. PubMed ID: 20098989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
    McQuade K; Gable D; Hohman S; Pearl G; Theune B
    J Vasc Surg; 2009 Jan; 49(1):109-15, 116.e1-9; discussion 116. PubMed ID: 19028055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Durability and efficacy of tibial arterial stent placement for critical limb ischemia.
    Silingardi R; Lauricella A; Coppi G; Chester J; Trevisi-Borsari G; Corvi V; Marcheselli L; Coppi G
    J Vasc Interv Radiol; 2015 Apr; 26(4):475-83.e2. PubMed ID: 25666627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. State-of-the-art treatment of common femoral artery disease.
    Nasr B; Kaladji A; Vent PA; Chaillou P; Costargent A; Patra P; Quillard T; Gouëffic Y
    J Cardiovasc Surg (Torino); 2015 Apr; 56(2):309-16. PubMed ID: 25644828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Duplex-guided endovascular treatment for occlusive and stenotic lesions of the femoral-popliteal arterial segment: a comparative study in the first 253 cases.
    Ascher E; Marks NA; Hingorani AP; Schutzer RW; Mutyala M
    J Vasc Surg; 2006 Dec; 44(6):1230-7; discussion 1237-8. PubMed ID: 17055689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endovascular treatment of complications of femoral arterial access.
    Tsetis D
    Cardiovasc Intervent Radiol; 2010 Jun; 33(3):457-68. PubMed ID: 20162284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salvage of angioplasty failures and complications in hemodialysis arteriovenous access using the FLUENCY Plus Stent Graft: technical and 180-day patency results.
    Dolmatch BL; Duch JM; Winder R; Butler GM; Kershen M; Patel R; Trimmer CK; Lopera JE; Davidson IJ
    J Vasc Interv Radiol; 2012 Apr; 23(4):479-87. PubMed ID: 22464712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Below-the-ankle angioplasty and stenting for limb salvage: anatomical considerations and long-term outcomes.
    Katsanos K; Diamantopoulos A; Spiliopoulos S; Karnabatidis D; Siablis D
    Cardiovasc Intervent Radiol; 2013 Aug; 36(4):926-35. PubMed ID: 23152042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of bifurcation patency after cross-over stenting of ostial lesions in superficial femoral artery: possible causes, prevention and reintervention.
    Jiang J; Chen B; Dong Z; Shi Y; Li W; Yue J
    Chin Med J (Engl); 2014; 127(18):3291-5. PubMed ID: 25266529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. German multicenter real-world registry of stenting for superficial femoral artery disease: clinical results and predictive factors for revascularization.
    Krankenberg H; Tübler T; Sixt S; Fischer M; Schmiedel R; Schulte KL; Balzer JO; Kieback A; Fiehn E; Wittenberg G; Ali T; Tiefenbacher C; Jahnke T; Steinkamp HJ; Wegscheider K; Treszl A; Ingwersen M; Zeller T
    J Endovasc Ther; 2014 Aug; 21(4):463-71. PubMed ID: 25101571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of above-the-knee prosthetic femoro-popliteal bypass versus percutaneous transluminal angioplasty and stenting for treatment of occlusive superficial femoral artery disease.
    Linnakoski H; Uurto I; Suominen V; Vakhitov D; Salenius J
    Scand J Surg; 2013; 102(4):227-33. PubMed ID: 24056137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators.
    Fischman DL; Leon MB; Baim DS; Schatz RA; Savage MP; Penn I; Detre K; Veltri L; Ricci D; Nobuyoshi M
    N Engl J Med; 1994 Aug; 331(8):496-501. PubMed ID: 8041414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cilostazol reduces angiographic restenosis after endovascular therapy for femoropopliteal lesions in the Sufficient Treatment of Peripheral Intervention by Cilostazol study.
    Iida O; Yokoi H; Soga Y; Inoue N; Suzuki K; Yokoi Y; Kawasaki D; Zen K; Urasawa K; Shintani Y; Miyamoto A; Hirano K; Miyashita Y; Tsuchiya T; Shinozaki N; Nakamura M; Isshiki T; Hamasaki T; Nanto S;
    Circulation; 2013 Jun; 127(23):2307-15. PubMed ID: 23652861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Duplex-guided balloon angioplasty and stenting for femoropopliteal arterial occlusive disease: an alternative in patients with renal insufficiency.
    Ascher E; Marks NA; Schutzer RW; Hingorani AP
    J Vasc Surg; 2005 Dec; 42(6):1108-13. PubMed ID: 16376200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.